A detailed history of Swiss National Bank transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Swiss National Bank holds 458,400 shares of ADMA stock, worth $7.51 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
458,400
Previous 429,900 6.63%
Holding current value
$7.51 Million
Previous $8.59 Million 8.52%
% of portfolio
0.01%
Previous 0.01%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$15.62 - $22.62 $445,170 - $644,670
28,500 Added 6.63%
458,400 $7.86 Million
Q3 2024

Nov 07, 2024

SELL
$11.21 - $20.03 $33,630 - $60,090
-3,000 Reduced 0.69%
429,900 $8.59 Million
Q2 2024

Aug 08, 2024

BUY
$5.98 - $11.18 $70,564 - $131,924
11,800 Added 2.8%
432,900 $4.84 Million
Q4 2023

Feb 06, 2024

SELL
$3.08 - $4.52 $57,596 - $84,523
-18,700 Reduced 4.25%
421,100 $1.9 Million
Q3 2023

Nov 08, 2023

BUY
$3.47 - $4.61 $14,921 - $19,823
4,300 Added 0.99%
439,800 $1.57 Million
Q2 2023

Aug 09, 2023

BUY
$3.12 - $4.22 $39,000 - $52,750
12,500 Added 2.96%
435,500 $1.61 Million
Q1 2023

May 10, 2023

SELL
$3.01 - $3.87 $148,393 - $190,791
-49,300 Reduced 10.44%
423,000 $1.4 Million
Q4 2022

Feb 08, 2023

BUY
$2.47 - $3.88 $1.17 Million - $1.83 Million
472,300 New
472,300 $1.83 Million

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.22B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.